NCT00003133View on ClinicalTrials.gov

Combination Chemotherapy Following Surgery in Treating Patients With Advanced Bladder Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 30, 1997

Primary Completion Date

January 31, 2003

Study Completion Date

January 31, 2003

Conditions
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and Ureter
Interventions
BIOLOGICAL

filgrastim

DRUG

cisplatin

DRUG

doxorubicin hydrochloride

DRUG

gemcitabine hydrochloride

DRUG

paclitaxel

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00003133 - Combination Chemotherapy Following Surgery in Treating Patients With Advanced Bladder Cancer | Biotech Hunter | Biotech Hunter